Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AG-13958 (AG-013958) (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular degeneration.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 123.00 | |
2 mg | In stock | $ 180.00 | |
5 mg | In stock | $ 349.00 | |
10 mg | In stock | $ 522.00 | |
25 mg | In stock | $ 847.00 | |
50 mg | In stock | $ 1,170.00 | |
100 mg | In stock | $ 1,580.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 350.00 |
Description | AG-13958 (AG-013958) (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular degeneration. |
Synonyms | AG-013958 |
Molecular Weight | 467.5 |
Formula | C26H22FN7O |
CAS No. | 319460-94-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/mL (10.70 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AG-13958 319460-94-1 Angiogenesis Tyrosine Kinase/Adaptors VEGFR Vascular endothelial growth factor receptor AG-013958 AG13958 inhibit AG 013958 AG 13958 AG013958 Inhibitor inhibitor